In summary, the findings presented in this paper provide the first in vivo experimental evidence that impaired glucose metabolism and utilization by activating the P38 MAPK kinase pathway triggers tau phosphorylation, neuronal apoptosis, impairs memory, synaptic integrity and function in a relevant transgenic mouse model of tauopathy. Here, MAPT is linked to tauopathy.